Many patients who begin GLP-1 therapy are curious about how quickly they can expect to see results
Inflation Reduction Act (effective 2027) may improve affordabilityparticularly for Medicare recipientscurrent dynamics underscore the complex interplay of clinical promise, economic burden, and political ideology .The rapid growth of GLP-1 prescribing marks a new chapter in the treatment of obesity
It also contains insulin and vitamin B complex
According to the Summaries of Product Characteristics (SmPCs), nausea is very common with most GLP-1 medications, while abdominal distension, eructation (belching), and flatulence are typically classified as common side effects, though frequencies differ between products
Yet cardiomyocytes, the main muscle cells of the heart, and hepatocytes in the liver do not appear to express GLP-1 or GIP receptors in significant amounts